Safieddin Safavi-Naeini was a Professor in the Department of Electrical and Computer Engineering and Director of the Centre for Intelligent Antenna and Radio Systems (CIARS) at his university. He specialized in advanced antenna systems, microwave engineering, radar technologies, and biomedical sensor design. His work emphasized high-frequency systems, phased array antennas, and mm-wave applications. Research Focus: His research spanned antenna design (e.g., defected ground structures, SIW-integrated arrays), mm-wave radar systems (including FMCW and SAR imaging), non-invasive biomedical sensors (e.g., glucose monitoring via microwave sensors), and satellite communication systems. He contributed to RFIC design, power amplifier technologies, and novel metamaterial-based components. Technological Contributions: Key innovations included tunable phase shifters, low-cost phased arrays for 5G/SATCOM, and compact high-gain antenna arrays. His work in graphene-based nonlinear optics and THz sources expanded into emerging applications like terahertz integrated circuits. Awards & Recognition: While no specific awards are listed, his prolific publication record and leadership in CIARS highlight his impactful contributions to the field. Advising & Labs: As director of CIARS, he oversaw research in intelligent antenna systems and radar imaging. His team developed cutting-edge systems like the 3D-printed scanning lens antenna and mm-wave FMCW target simulators.
Timothy Bardouille is an Associate Professor and Undergraduate Program Coordinator at Dalhousie University, affiliated with the Faculty of Science and cross-appointed with the School of Biomedical Engineering, Department of Diagnostic Radiology, Department of Psychology and Neuroscience, and the School of Physiotherapy. He holds a PhD from the University of Toronto, an MSc from Dalhousie University, and a BSc (Hon) from Queen's University, Kingston, ON. His research focuses on non-invasive neuroimaging technologies , including magnetoencephalography (MEG) with optically pumped magnetometers, and the development of advanced software/hardware for brain imaging and data analysis. The Biosignal Lab , which he leads, explores neural networks, brain plasticity post-injury, and machine learning applications in neuroimaging. Doctor of Philosophy, University of Toronto Master of Science, Dalhousie University Bachelor of Science (Hon), Queen's University, Kingston, ON
Dr. Leslie Scoutt is a Professor of Radiology and Biomedical Imaging at Yale School of Medicine, serving as Vice Chair for Education and Medical Director of the Non-Invasive Vascular Lab. She specializes in diagnostic ultrasound, particularly vascular and gynecologic imaging, with expertise in renal and liver transplant imaging. Her clinical practice includes first-trimester obstetric ultrasound, transrectal ultrasound for anal incontinence, and vascular assessments for conditions like abdominal aortic aneurysms. Education: BA in Biology, Wesleyan University (1974) MD, University of Rochester School of Medicine (1978) Residencies: Internal Medicine (University Hospital, 1979), Radiology (Beth Israel Hospital, Boston, 1985) Fellowship: Yale University School of Medicine (1987) MA in Arts, Yale University (2002) Her research focuses on optimizing ultrasound techniques for vascular and pelvic imaging, alongside initiatives in medical education. She has authored numerous peer-reviewed articles and book chapters, emphasizing imaging innovations and clinical guidelines. Dr. Scoutt’s awards include the RSNA Honored Educator Award (2014), multiple Mentor of the Year recognitions (YSM), and the Society of Radiologists in Ultrasound’s Distinguished Educator Award (2020). She has held leadership roles in national organizations like the American Board of Radiology and the American Registry of Radiologic Technologists. Administratively, she chairs educational committees and collaborates on translational research through Yale’s imaging studios. Her clinical and academic work bridges cutting-edge imaging with patient-centered care, emphasizing interdisciplinary teamwork and mentorship.
Vincent Mase, Jr., MD, FACS is an Assistant Professor of Surgery specializing in Thoracic Surgery at Yale School of Medicine. He serves as Program Director for the Cardiothoracic I-6 Residency and as site director of Bridgeport Hospital Thoracic Surgery. Dr. Mase treats patients across multiple Yale Medicine locations including Yale New Haven Hospital, Bridgeport Hospital, and Park Avenue Medical Center in Trumbull. Dr. Mase's educational background includes a BS in Neuroscience from Trinity College (1995), MD from University of Vermont College of Medicine (2002), General Surgery Internship at Walter Reed Army Medical Center (2003), General Surgery Residency at Fletcher Allen Healthcare (2012), and Thoracic Surgery Fellowship at Brigham and Women's Hospital (2016). He is board-certified in both general surgery (ACS) and thoracic surgery (ABTS). His clinical expertise focuses on the surgical treatment of lung cancer, chest wall deformities, and other chest-related conditions using minimally invasive techniques. Dr. Mase emphasizes patient education, ensuring patients and families understand both surgical and non-surgical options. His research interests include quality outcomes research and lung cancer screening processes, with numerous publications in leading journals examining lung cancer treatment approaches, surgical decision-making, and the impact of healthcare disruptions on cancer screening. Dr. Mase's work shows a consistent focus on improving thoracic surgical outcomes, particularly in lung cancer treatment where he has contributed to evidence-based guidelines for surgical resection approaches. His research demonstrates expertise in analyzing treatment options for stage I non-small cell lung cancer, evaluating the comparative effectiveness of different surgical approaches versus radiation therapy. Bronze Star Medal Meritorious Service Medal Combat Medical Badge Dr. Mase serves as a Lieutenant Colonel in the U.S. Army Reserves with nearly 20 years of combined active duty and reserve service. His military assignments have included postings in Schweinfurt, Germany; Seoul, South Korea; and a combat tour in Tikrit, Iraq. He maintains strong connections between his military and civilian medical careers, bringing his extensive operational experience to his clinical practice and research. At Yale, he collaborates extensively with colleagues in the Center for Thoracic Cancers and Lung Cancer Screening Program, contributing to multidisciplinary approaches to thoracic disease management. Dr. Mase operates within the Thoracic Surgery division of Yale's Department of Surgery, which is part of the Yale Cancer Center. His clinical work spans multiple sites across the Yale New Haven Health System, providing comprehensive thoracic surgical care to patients throughout Connecticut. He is particularly noted for his patient-centered approach, considering all patients as success stories and finding fulfillment in seeing them recover and resume normal life activities.
Lee Ying, MD, PhD, MS, MPhil is a researcher and clinician affiliated with the Ahuja Lab at Yale School of Medicine. They completed their MD at Yale School of Medicine (2020) and hold advanced degrees in Pharmacology from Yale Graduate School, including a PhD (2019), MS (2018), and MPhil (2018). Their undergraduate degree is in Molecular and Cellular Biology from UC Berkeley (2011). Dr. Ying’s research focuses on obesity, oncology, and surgical outcomes, with particular emphasis on bariatric surgery techniques, pancreatic cancer, and health equity in surgical care. Their work spans clinical research, epidemiological analysis, and translational studies. Key research areas include robotic surgical techniques, metabolic surgery outcomes in diverse populations, and molecular biomarkers for pancreatic malignancies. Collaborations with surgeons like Nita Ahuja and Saber Ghiassi reflect multidisciplinary engagement. Their publications analyze preoperative risk factors (e.g., hypoalbuminemia), postoperative complications, and disparities in ventral hernia repair. Recent work explores stapling platform influences on robotic sleeve gastrectomy outcomes and the role of promoter hypermethylation in cancer risk stratification. Dr. Ying’s articles highlight trends in evidence-based surgical guidelines (e.g., Roux-en-Y gastric bypass pathways), pandemic-era surgical safety, and epigenetic approaches to early cancer detection. Their contributions bridge clinical practice and research, addressing both technical and equity-related challenges in surgical care. Notably, they advise no students but contribute to team-based studies involving residents and fellows. Their work is rooted in the Ahuja Lab, emphasizing translational oncology and surgical innovation.
Associate Professor Rebecca Kozor is an academic and clinical cardiologist affiliated with the Northern Clinical School at the University of Sydney and Royal North Shore Hospital. She holds roles in cardiology, specializing in cardiac imaging (MRI, CT, echocardiography) and clinical research. Her expertise includes Fabry disease, heart muscle disorders, and environmental sustainability in healthcare. She co-directs the University of Sydney CMR Group and leads research projects funded by grants focusing on diagnostic imaging, cardiovascular disease, and chronic kidney disease. Education: BSc(Med), MBBS, PhD (University of New South Wales), FRACP, FCSANZ Clinical Roles: Consultant Cardiologist at Royal North Shore Hospital and private practices (Mosman Cardiology, North Shore Private Hospital) Leadership: President of Australia New Zealand Working Group for Cardiovascular MRI, Member of Cardiac Society of Australia and New Zealand Scientific Committee Research and Clinical Focus Dr. Kozor’s research spans cardiac imaging advancements, Fabry disease pathophysiology, and women’s cardiovascular health. Key projects include: Development of CMR competency curricula Environmental impact of cardiac imaging Diagnosis and management of genetic cardiomyopathies Clinical trials evaluating CMR in acute coronary syndromes Grants and Awards Recent grants include studies on: Cost-benefit analysis of Rapid Access Chest Pain Clinics (2022) Cardiac risk in Fabry disease (2018) Lifestyle interventions for coronary heart disease (2022) Teaching and Mentorship Supervises higher degree research students in cardiac imaging and genetic cardiomyopathies. Active in medical student research programs and CMR education. Labs/Teams: Cardiovascular Magnetic Resonance Group, University of Sydney; Fabry Disease Research Collaborative.
Mark Everett is a Professor of Geophysics at Texas A&M University, holding the Howard Karren Professorship. His primary research focuses on near-surface applied geophysics, with expertise in ground-penetrating radar (GPR), electrical resistivity tomography, and controlled-source electromagnetics. He explores applications in environmental monitoring, geotechnical engineering, archaeology, and agricultural sciences. Research interests include karst aquifer dynamics, coastal transition zones, and subsurface imaging for infrastructure assessment. Teaches courses like GEOP 313 (Geophysical Field Methods) and GEOP 413 (Near-Surface Applied Geophysics). Education background: BSc and MSc in Physics from York University (Canada), followed by a PhD in Geophysics from the University of Toronto. Research highlights: Developed the SWAN CSEM system for offshore groundwater mapping. Advanced GPR techniques for unmarked grave detection and crop biomass estimation. Led studies on sinkhole formation mechanisms and coastal aquifer connectivity. Publications emphasize hydrogeological processes, geophysical instrumentation, and interdisciplinary applications in agriculture and archaeology. Collaborates globally on projects like the Texas Water Observatory, focusing on climate-land use interactions in water cycle dynamics.
Professor Jimmy Bell at the University of Westminster leads the Research Centre for Optimal Health, focusing on mechanisms of phenotypic flexibility, metabolic dysfunction, and accelerated ageing. His interdisciplinary research integrates quantum biology, metabolic phenotyping, and AI-driven analytics. As Principal Investigator for the UK Biobank Enhanced Phenotyping study, he develops novel assessment technologies for metabolic health. Research interests span mitochondrial function, adipose tissue biology, obesity pathogenesis, and metabolic disorders. His work bridges quantum-scale biological processes with population-level health outcomes, emphasizing technological innovation in health assessment. Publications demonstrate strong focus on metabolic imaging, genetic epidemiology, and computational modeling. Recent work utilizes deep learning for disease prediction, MRI-based phenotyping, and targeted cancer therapies. Longitudinal analyses in cohort studies reveal mechanisms linking adiposity to chronic diseases. Professional activities include grant review for major UK research councils, PhD examination internationally, and leadership in large-scale biobank operations. Leads multidisciplinary teams at the Research Centre for Optimal Health and collaborates with Health Data Science groups to develop novel assessment frameworks for metabolic health.
Emanuela Volpi is a Professor in the School of Life Sciences at the University of Westminster, affiliated with the College of Liberal Arts and Sciences. She holds a PhD in Evolutionary Biology from the University of Rome ‘La Sapienza’ and has extensive postdoctoral experience at Cancer Research UK and the Wellcome Trust Centre for Human Genetics. Her expertise spans medical molecular genetics, genome functional organization, nuclear architecture, and cancer biomarker research. She leads research on genome-environment interactions and their health impacts, with high-impact publications in journals like Science and Nature Communications . Teaching roles include Module Leader for L5 Genetics in Medicine and L7 Post-Graduate Project , and co-Course Leader for the Master’s in Biomedical Sciences. Her research focuses on genomic instability in obesity, CD180 signaling in cancers, and translational biomarkers. She is Editor-in-Chief of Molecular Cytogenetics and chairs the European Cytogeneticists Association’s ‘Chromosome Stability, Integrity and Dynamics’ working group. Key awards include Fellowships from the Royal Society of Biology and the Higher Education Academy. Her advisory roles span national and international committees, emphasizing her leadership in medical genetics and education. Current projects explore precision medicine, AI regulation in healthcare, and pediatric obesity biomarkers, with a focus on early intervention strategies.
Dr. Soshian Sarrafpour is an Assistant Professor of Ophthalmology and Visual Science at Yale School of Medicine. He specializes in glaucoma, cataracts, and anterior segment diseases, providing clinical care at multiple Yale Medicine locations. His academic roles include faculty membership in the Glaucoma Research Group and involvement in resident/fellow education. Education & Training: Bachelor of Science in Biochemistry, Tufts University (2011) Medical Doctorate, Tufts University School of Medicine (2015) Ophthalmology Residency, New York University (2019) Glaucoma Fellowship, Yale University (2020) Research Focus: Combines clinical practice with innovative studies in: Machine learning applications for glaucoma diagnosis Minimally invasive glaucoma surgeries (e.g., OMNI procedure) Advanced imaging techniques for ocular disease evaluation Medical education strategies in ophthalmology Key Contributions: Has authored/co-authored over 15 peer-reviewed articles, contributed to Shield's Textbook of Glaucoma , and presented at major conferences like ARVO and AAO. His translational research bridges surgical innovation with clinical outcomes. Labs/Teams: Active member of the Yale Glaucoma Research Group , collaborating on projects involving novel surgical techniques, imaging modalities, and disease mechanism studies.
Dr. Erin Faherty is an Assistant Professor of Pediatrics at Yale School of Medicine and serves as Director of Inpatient Pediatric Cardiology at Yale New Haven Children's Hospital. She specializes in diagnosing and managing cardiac conditions in neonates through adolescents, particularly critical cases requiring hospitalization. Education includes: BA in Chemistry, College of the Holy Cross (2007) MD, Stony Brook University (2012) Residency and fellowship training at Yale New Haven Hospital and Mount Sinai Kravis Children's Hospital Her research focuses on: Pediatric myocarditis diagnosis and management COVID-19 cardiovascular impacts in children Congenital heart disease interventions Echocardiography applications Recent publications center on cardiac complications of COVID-19 vaccination, MIS-C, and innovative diagnostic approaches using biomarkers and imaging. Awards: Yale Department of Pediatrics Faculty Honor Roll (2019, 2020, 2023) Magna Cum Laude (2007) Clinical work involves multidisciplinary collaboration with cardiac surgeons, imaging specialists, and pediatric teams to manage complex cases.
Lara Nonell is an Associate Professor in the Department of Biosciences at the University of Vic – Central University of Catalonia and Head of the Bioinformatics Unit. She holds a Doctorate in Biomedicine from Pompeu Fabra University (2019) and has expertise in bioinformatics, cancer diagnostics, and multiomics data analysis. Her research focuses on developing computational methods for biomarker identification and cancer progression modeling. Education Doctorate in Biomedicine, Pompeu Fabra University (2019) MSc in Information Technology Management, La Salle Ramon Llull University (2000) Bachelor’s in Mathematics, Autonomous University of Barcelona (1996) Research Interests Dr. Nonell’s work integrates machine learning, bioinformatics pipelines, and multiomics data to drive precision oncology. Key areas include: Biomarker development for cancer diagnostics Epithelial-mesenchymal transition mechanisms in metastasis Gene expression profiling in leukemias and lymphomas Systems biology approaches to comorbidities like diabetes and cancer Publications Her 20+ peer-reviewed articles (2019-2023) span oncology, immunology, and bioinformatics. Recent work includes: Epigenetic drivers of hepatoblastoma progression MYC-driven gene signatures in melanoma prognosis MicroRNA regulation in cutaneous lymphomas Grants & Labs Leads the Bioinformatics Unit supporting VHIO research. Collaborations include multi-institutional projects in Barcelona’s biomedical ecosystem. No specific grants mentioned in the text.
Dionisios Sakkas is a Researcher at Yale University's Yale School of Medicine, specifically within the Department of Obstetrics, Gynecology & Reproductive Sciences. He holds a PhD from Monash University (1990). His research focuses on reproductive medicine, embryology, and assisted reproductive technologies, with particular emphasis on improving IVF outcomes through genetic screening and non-invasive diagnostic methods. Key areas include preimplantation genetic testing (PGT-A), aneuploidy detection, and optimizing embryo selection protocols. His work also explores the role of sperm factors in embryonic development and innovative applications of artificial intelligence in reproductive diagnostics. Recent studies investigate the clinical efficacy of PGT-A on live birth rates, comparisons between cell-free DNA and trophectoderm biopsy techniques, and validation of home-based semen analysis protocols. He has contributed to ethical discussions around embryo sex selection and published comparative analyses of carrier screening panels in reproductive medicine. His research integrates interdisciplinary approaches from biotechnology and clinical practice to advance fertility treatment strategies. While no specific grants or awards are listed in the provided text, his extensive publication record (over 48 publications) demonstrates sustained contributions to reproductive science. Collaborative projects involve multi-center studies and international teams addressing challenges in IVF efficacy and genetic counseling practices.
Matti Mäntysalo is a Professor in the Department of Electrical Engineering at the Faculty of Information Technology and Communication Sciences, Tampere University. His research focuses on advanced materials for energy storage systems, printed electronics, and biomedical applications. He leads projects on supercapacitors, flexible/stretchable electronics, and biosensors, with a strong emphasis on sustainability and biodegradability. Mäntysalo has authored over 130 publications and contributed to initiatives like the ECOtronics research project (2019–2022). His work integrates material science, nanotechnology, and engineering to develop next-generation energy storage solutions and wearable medical devices. Key contributions include dopamine-functionalized supercapacitors, piezoelectric PLLA sensors for cardiovascular monitoring, and 3D-printed biodegradable electrodes. He also explores scalable manufacturing techniques such as roll-to-roll printing for monolithic supercapacitors and membrane-based energy systems. Mäntysalo serves as an editorial board member for special issues on flexible sensors and MEMS technologies. His research bridges fundamental science and practical applications, addressing challenges in IoT, smart packaging, and sustainable electronics. Recent efforts include self-powered e-tattoo sensors and zero-discharge microbial electrolysis cells.
Markku Hauta-Kasari is the 1st Vice Dean and a Professor of Computer Science at the University of Eastern Finland (UEF), affiliated with the School of Computing under the Faculty of Science, Forestry and Technology. He holds a MSc (1994) and PhD (1999) in computer science and information processing from the University of Kuopio and Lappeenranta University of Technology, respectively. His career includes roles as Director of InFotonics Center Joensuu (2003–2010) and Head of the School of Computing (2014–2021). As a researcher, he focuses on spectral color science, pattern recognition, and computer vision with applications in biomedical imaging, material analysis, and clinical diagnostics. His work bridges academia and industry through projects like the BioColour Library and the ODSI-DB dental imaging database. Key research areas include hyperspectral imaging for tumor detection, spectral analysis of biological tissues, and optimizing light sources for medical visualization. He has led over 50 peer-reviewed publications and contributed to international collaborations, including visiting research roles in Japan. He chairs the Pattern Recognition Society of Finland and the CIE TC8-07 Technical Committee on Multispectral Imaging. Hauta-Kasari’s innovations span clinical tools like real-time spectral imaging systems for neurosurgery and dental diagnostics, leveraging machine learning for improved diagnostic accuracy. His laboratories emphasize interdisciplinary approaches to solve challenges in medicine, forestry, and material science.
